PCR-based MRD testing for acute lymphoblastic leukaemia in India
Main Authors: | Rubina Islam, Debparna Saha, Debdutta Ganguli, Arindam Basu, Neeraj Arora, Deepak Mishra, Vaskar Saha, Shekhar Krishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Pediatric Hematology Oncology Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S246812451730205X |
Similar Items
-
Evolving strategies in the management of relapsed acute lymphoblastic leukaemia – TMCKidsALLR1
by: Prakriti Roy, et al.
Published: (2017-01-01) -
Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia
by: O'Connor, D, et al.
Published: (2017) -
Therapeutic drug monitoring informs asparaginase dose scheduling in the InPOG-ALL-15-01-ICiCLe-ALL-14 trial
by: Jasmeet Sidhu, et al.
Published: (2017-01-01) -
Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata
by: Debjani Ghosh, et al.
Published: (2022-01-01) -
Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
by: Tushar Mungle, et al.
Published: (2023-02-01)